Product Details
Auro-Amoxiclav
Amoxicillin + Clavulanic Acid875 mg + 125 mg
Tablet
DIN/PIN/NPN
02471701
Manufacturer
Auro Pharma Inc.
Formulary Listing Date
2022-04-29
Unit Price
0.5551
Amount MOH Pays
0.5551
Coverage Status
General Benefit
ODB Formulary Therapeutic Classification
Therapeutic Note
Amoxicillin + Clavulanic Acid: Amoxicillin/clavulanic acid is not recommended as first line treatment for acute otitis media and sinusitis. Antibiotic resistance (H. influenzae, M. catarrhalis) due to B-lactamase production has caused only a minority of treatment failures with amoxicillin. Amoxicillin/clavulanic acid is first line treatment for infected bites of cat, dog or human.
ATC Code
J01CR02
Interchangeable Products
| DIN/ PIN/ NPN | Brand name | Unit Price | Amount MOH pays |
|---|---|---|---|
| 02482584 | Sandoz Amoxi-Clav Tablets | 0.5551 | 0.5551 |
| 02238829 | Clavulin (BID) | 2.7515 | 0.5551 |
| 02245623 | Apo-Amoxi Clav | 0.5551 | 0.5551 |
| 02471701 | Auro-Amoxiclav | 0.5551 | 0.5551 |
| 02508265 | Jamp Amoxi Clav | 0.5551 | 0.5551 |
| 02536048 | Amoxicillin/Clav | 0.5551 | 0.5551 |